Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide

Fabienne Willems(Université Libre de Bruxelles), Michel Goldman(German Cancer Research Center), Valérie Verhasselt(German Cancer Research Center), Ezra Aksoy(Queen Mary University of London), Peter H. Krammer(Slovak Academy of Sciences), Carsten Scaffidi(National Institutes of Health), Nathalie Vanderheyde(German Cancer Research Center), Zoulikha Amraoui(German Cancer Research Center), Marcus E. Peter(Northwestern University)
Blood
June 1, 2000
10.1182/blood.v95.11.3478
Cited by 98

Related Papers

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Two CD95 (APO-1/Fas) signaling pathways
|The EMBO Journal|1998|3k
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
|Genes & Development|2008|2.3k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k